HLQVX
Price
$19.74
Change
-$0.60 (-2.95%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

HLQVX vs RMFCX

Header iconHLQVX vs RMFCX Comparison
Open Charts HLQVX vs RMFCXBanner chart's image
JPMorgan Large Cap Value I
Price$19.74
Change-$0.60 (-2.95%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
HLQVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLQVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLQVX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. HLQVX (5.03B). RMFCX pays higher dividends than HLQVX: RMFCX (1.69) vs HLQVX (1.50). HLQVX was incepted earlier than RMFCX: HLQVX (34 years) vs RMFCX (23 years). HLQVX is a more actively managed with annual turnover of: 143.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than HLQVX: RMFCX (250) vs HLQVX (1000000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. HLQVX (10.19). HLQVX (42.01) and RMFCX (40.39) have equivalent 5 years return.
HLQVXRMFCXHLQVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence34 years23 years-
Gain YTD9.22711.42381%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.03B98.7B5%
Annual Yield % from dividends1.501.6988%
Returns for 1 year10.1912.6381%
Returns for 3 years15.1814.16107%
Returns for 5 years42.0140.39104%
Returns for 10 years53.9161.8487%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc